GreenLight Biosciences (GRNA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GreenLight Biosciences

    NASDAQ: GRNA · Real-Time Price · USD
    0.30
    0.00 (0.13%)
    At close: Jul 21, 2023, 10:00 PM

    GreenLight Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 6.38M n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 6.38M n/a
    Operating Income
    		 -163.92M -108.56M
    Interest Income
    		 895K 37K
    Pretax Income
    		 -165.96M -112.31M
    Net Income
    		 -167.06M -114.73M
    Selling & General & Admin
    		 35.93M 20.32M
    Research & Development
    		 133.81M 89.83M
    Other Expenses
    		 -396K -1.59M
    Operating Expenses
    		 169.34M 108.56M
    Interest Expense
    		 4.12M 2.42M
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 169.34M 108.56M
    Income Tax Expense
    		 1.09M 2.42M
    Shares Outstanding (Basic)
    		 131.98M 122.82M
    Shares Outstanding (Diluted)
    		 131.98M 122.82M
    EPS (Basic)
    		 -1.27 -0.93
    EPS (Diluted)
    		 -1.27 -0.93
    EBITDA
    		 -153.99M -102.75M
    EBIT
    		 -161.84M -108.1M
    Depreciation & Amortization
    		 9.93M 5.81M

    Add to Watchlist